Recovery peptides reach athletes through training rooms and group chats long before they reach a clinician. The consequence of a casual answer is not medical, it is a sanction.
Prohibited status cannot be reasoned out from what a compound does. Two peptides with near-identical mechanisms can sit on opposite sides of the WADA list, so inference is exactly the wrong instinct.
That is why the anti-doping table treats an unconfirmed compound as unconfirmed and shows it in neutral grey. It never presents a guess as a permission, because a wrong permitted is the one error that gets an athlete banned.
A dedicated table recording WADA position per compound, being populated entry by entry against the published list. Anything not yet confirmed is shown as unconfirmed rather than assumed safe.
Which recovery peptides have human data behind them and which rest on preclinical work, tiered so the difference is visible at a glance.
74 protocol sheets covering what each compound does, what has been studied, and what would rule it out.
Full access to the protocol reference, compliance guides and regulatory briefings.
Get Professional access → Or see everything that is included